PCSK9 inhibition protects mice from food allergy
Transl Res. 2024 Mar 10:S1931-5244(24)00048-3. doi: 10.1016/j.trsl.2024.03.001. Online ahead of print.ABSTRACTThe Proprotein Convertase Subtilisin Kexin of type 9 (PCSK9) has been identified in 2003 as the third gene involved in familial hypercholesterolemia. PCSK9 binds to the membrane low-density lipoprotein receptor (LDLR) and promotes its cellular internalization and lysosomal degradation. Beyond this canonical role, PCSK9 was recently described to be involved in several immune responses. However, to date, the contribution of PCSK9 in food allergy remains unknown. Here, we showed that Pcsk9 deficiency or pharmacological inhibition of circulating PCSK9 with a specific monoclonal antibody (m-Ab) protected mice against symptoms of gliadin-induced-food allergy, such as increased intestinal transit time and ear oedema. Furthermore, specific PCSK9 inhibition during the elicitation steps of allergic process was sufficient to ensure anti-allergic effects in mice. Interestingly, the protective effect of PCSK9 inhibition against food allergy symptoms was independent of the LDLR as PCSK9 inhibitors remained effective in Ldlr deficient mice. In vitro, we showed that recombinant gain of function PCSK9 (PCSK9 D374Y) increased the percentage of mature bone marrow derived dendritic cells (BMDCs), promoted naïve T cell proliferation and potentiated the gliadin induced basophils degranulation. Altogether, our data demonstrate that PCSK9 inhibition is protective against gliadin induced foo...
Source: Translational Research : the journal of laboratory and clinical medicine - Category: Laboratory Medicine Authors: Victoria Lorant Martin Klein Damien Gar çon Thibaud Sotin Samuel Frey Marie-Aude Cheminant Audrey Ayer Mika ël Croyal Laurent Flet Antoine Rimbert Luc Colas Bertrand Cariou Gr égory Bouchaud C édric Le May Source Type: research
More News: Allergy | Allergy & Immunology | Chemistry | Food Allergy | Genetics | Laboratory Medicine